Dialysis Disruptor NephroCare Preps for IPO with ₹8 Crore Power Up!

Dialysis Disruptor NephroCare Preps for IPO with ₹8 Crore Power Up!

🌐 Expansion Plans: The funding will help Nephrocare India establish 22 high-end kidney care facilities across India by March 2026.

🤝 Investors: Marquee investors include Deepak Parekh, Bharat Shah, and Rajendra Agarwal.

🏥 Operational Timeline: Four kidney care centers expected to be operational by the end of the current fiscal year.

🎯 Long-Term Vision: Nephrocare’s goal is to establish 300 centers nationwide within the next 8-10 years.

⚕️ Critical Need: Highlighting the demand for kidney care, officials point out the limited access with only 12,881 haemodialysis centers for an estimated seven crore patients with chronic kidney diseases.

📈 Health Stats: India, known as the ‘diabetes capital,’ adds about 2.5 lakh new dialysis-dependent patients annually due to advanced kidney conditions.

🌍 National Impact: One in eleven Indians is susceptible to renal failure, often linked to diabetes and hypertension.

🚀 Industry Context: The expansion addresses the critical gap in the face of approximately 2.5 lakh new dialysis-dependent patients added annually in India.

🗓️ Timeframe: The company aims to achieve its goals within 8-10 years, emphasizing the urgency of addressing the vast demand for kidney care.

Thanks for reading this post, kagaar!

Related Articles

Responses

Your email address will not be published. Required fields are marked *